Prospective approaches to enhancing CAR T cell therapy for glioblastoma
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prospective approaches to enhancing CAR T cell therapy for glioblastoma
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 13, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-10-06
DOI
10.3389/fimmu.2022.1008751
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting Cancer-Associated Fibroblasts in the Bone Marrow Prevents Resistance to CART-Cell Therapy in Multiple Myeloma
- (2022) Reona Sakemura et al. BLOOD
- Recruitment and activation of type 3 innate lymphoid cells promote antitumor immune responses
- (2022) Mélanie Bruchard et al. NATURE IMMUNOLOGY
- CRISPR activation and interference screens decode stimulation responses in primary human T cells
- (2022) Ralf Schmidt et al. SCIENCE
- Dose-dependent thresholds of dexamethasone destabilize CAR T-cell treatment efficacy
- (2022) Alexander B. Brummer et al. PLoS Computational Biology
- Enhanced safety and efficacy of protease-regulated CAR-T cell receptors
- (2022) Louai Labanieh et al. CELL
- Engineering the next-generation of CAR T-cells with CRISPR-Cas9 gene editing
- (2022) Alexander Dimitri et al. Molecular Cancer
- CAR T cell killing requires the IFNγR pathway in solid but not liquid tumours
- (2022) Rebecca C. Larson et al. NATURE
- A genome-scale screen for synthetic drivers of T cell proliferation
- (2022) Mateusz Legut et al. NATURE
- PSMA-targeting TGFβ-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer: a phase 1 trial
- (2022) Vivek Narayan et al. NATURE MEDICINE
- Oncolytic virus–mediated expansion of dual-specific CAR T cells improves efficacy against solid tumors in mice
- (2022) Laura Evgin et al. Science Translational Medicine
- Interferon-a potentiates anti-PD-1 efficacy by remodeling glucose metabolism in the hepatocellular carcinoma microenvironment
- (2022) Bo Hu et al. Cancer Discovery
- CAR T cell therapy and the tumor microenvironment: Current challenges and opportunities
- (2022) Lionel A. Kankeu Fonkoua et al. Molecular Therapy-Oncolytics
- Leukemic extracellular vesicles induce chimeric antigen receptor T cell dysfunction in chronic lymphocytic leukemia
- (2021) Michelle J. Cox et al. MOLECULAR THERAPY
- Reversible ON- and OFF-switch chimeric antigen receptors controlled by lenalidomide
- (2021) Max Jan et al. Science Translational Medicine
- Preclinical assessment of the efficacy and specificity of GD2-B7H3 SynNotch CAR-T in metastatic neuroblastoma
- (2021) Babak Moghimi et al. Nature Communications
- T cell circuits that sense antigen density with an ultrasensitive threshold
- (2021) Rogelio A. Hernandez-Lopez et al. SCIENCE
- In vivo CART Cell Imaging: Paving the Way for Success in CART Cell Therapy
- (2021) Reona Sakemura et al. Molecular Therapy-Oncolytics
- Navigating CAR-T cells through the solid-tumour microenvironment
- (2021) Andrew J. Hou et al. NATURE REVIEWS DRUG DISCOVERY
- SynNotch CAR circuits enhance solid tumor recognition and promote persistent antitumor activity in mouse models
- (2021) Axel Hyrenius-Wittsten et al. Science Translational Medicine
- SynNotch-CAR T cells overcome challenges of specificity, heterogeneity, and persistence in treating glioblastoma
- (2021) Joseph H. Choe et al. Science Translational Medicine
- Interrogating immune cells and cancer with CRISPR-Cas9
- (2021) Frank A. Buquicchio et al. TRENDS IN IMMUNOLOGY
- CDK4/6 inhibition promotes anti-tumor immunity through the induction of T cell memory
- (2021) Emily J Lelliott et al. Cancer Discovery
- Epigenetic strategies to boost CAR T cell therapy
- (2021) Behnia Akbari et al. MOLECULAR THERAPY
- The 2021 WHO Classification of Tumors of the Central Nervous System: a summary
- (2021) David N Louis et al. NEURO-ONCOLOGY
- Engineering genetic devices for in vivo control of therapeutic T cell activity triggered by the dietary molecule resveratrol
- (2021) Linfeng Yang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Glioblastoma: clinical presentation, diagnosis, and management
- (2021) Chris McKinnon et al. BMJ-British Medical Journal
- Development of a Clinically Relevant Reporter for Chimeric Antigen Receptor T-cell Expansion, Trafficking, and Toxicity
- (2021) Reona Sakemura et al. Cancer Immunology Research
- Control of the activity of CAR-T cells within tumours via focused ultrasound
- (2021) Yiqian Wu et al. Nature Biomedical Engineering
- Enhanced intratumoural activity of CAR T cells engineered to produce immunomodulators under photothermal control
- (2021) Ian C. Miller et al. Nature Biomedical Engineering
- An NK-like CAR T cell transition in CAR T cell dysfunction
- (2021) Charly R. Good et al. CELL
- Nano-optogenetic engineering of CAR T cells for precision immunotherapy with enhanced safety
- (2021) Nhung Thi Nguyen et al. Nature Nanotechnology
- Deleting DNMT3A in CAR T cells prevents exhaustion and enhances antitumor activity
- (2021) Brooke Prinzing et al. Science Translational Medicine
- PTP1B is an intracellular checkpoint that limits T cell and CAR T cell anti-tumor immunity
- (2021) Florian Wiede et al. Cancer Discovery
- In vivo genome-wide CRISPR screens identify SOCS1 as intrinsic checkpoint of CD4 + T H 1 cell response
- (2021) Aurélien Sutra Del Galy et al. Science Immunology
- Feasibility and efficacy of CD19-targeted CAR-T cells with concurrent ibrutinib for CLL after ibrutinib failure
- (2020) Jordan Gauthier et al. BLOOD
- CXCR2‐modified CAR‐T cells have enhanced trafficking ability that improves treatment of hepatocellular carcinoma
- (2020) Guangna Liu et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Pooled Knockin Targeting for Genome Engineering of Cellular Immunotherapies
- (2020) Theodore L. Roth et al. CELL
- Cytokine IL-36γ improves CAR T-cell functionality and induces endogenous antitumor response
- (2020) Xinghuo Li et al. LEUKEMIA
- Adoptive cellular therapy with T cells expressing the dendritic cell growth factor Flt3L drives epitope spreading and antitumor immunity
- (2020) Junyun Lai et al. NATURE IMMUNOLOGY
- Synthesis and evaluation of designed PKC modulators for enhanced cancer immunotherapy
- (2020) Clayton Hardman et al. Nature Communications
- Chimeric Antigen Receptor Designed to Prevent Ubiquitination and Downregulation Showed Durable Antitumor Efficacy
- (2020) Wentao Li et al. IMMUNITY
- Emerging immunotherapies for malignant glioma: from immunogenomics to cell therapy
- (2020) Gavin P Dunn et al. NEURO-ONCOLOGY
- Successful treatment of T315I BCR-ABL mutated lymphoid blast phase chronic myeloid leukemia with chimeric antigen receptor T cell therapy followed by dasatinib
- (2020) Hao Zhang et al. Regenerative Therapy
- CAR T Cell Therapy for Solid Tumors: Bright Future or Dark Reality?
- (2020) Jessica Wagner et al. MOLECULAR THERAPY
- Effective combination immunotherapy using oncolytic viruses to deliver CAR targets to solid tumors
- (2020) Anthony K. Park et al. Science Translational Medicine
- EZH2 Inhibition in Ewing Sarcoma Upregulates GD2 Expression for Targeting with Gene-Modified T Cells
- (2019) Sareetha Kailayangiri et al. MOLECULAR THERAPY
- Clinical presentation, management, and biomarkers of neurotoxicity after adoptive immunotherapy with CAR T-cells
- (2019) Philipp Karschnia et al. BLOOD
- Modulation of Target Antigen Density Improves CAR T Cell Functionality and Persistence
- (2019) Sneha Ramakrishna et al. CLINICAL CANCER RESEARCH
- CAR-T cells secreting BiTEs circumvent antigen escape without detectable toxicity
- (2019) Bryan D. Choi et al. NATURE BIOTECHNOLOGY
- The tyrosine kinase inhibitor dasatinib acts as a pharmacologic on/off switch for CAR T cells
- (2019) Katrin Mestermann et al. Science Translational Medicine
- Decitabine enhances cytotoxic effect of T cells with an anti-CD19 chimeric antigen receptor in treatment of lymphoma
- (2019) Sujun Li et al. OncoTargets and Therapy
- CAIX-specific CAR-T Cells and Sunitinib Show Synergistic Effects Against Metastatic Renal Cancer Models
- (2019) Huizhong Li et al. JOURNAL OF IMMUNOTHERAPY
- CXCR1- or CXCR2-modified CAR T cells co-opt IL-8 for maximal antitumor efficacy in solid tumors
- (2019) Linchun Jin et al. Nature Communications
- CAR exosomes derived from effector CAR-T cells have potent antitumour effects and low toxicity
- (2019) Wenyan Fu et al. Nature Communications
- Engineering strategies to overcome the current roadblocks in CAR T cell therapy
- (2019) Sarwish Rafiq et al. Nature Reviews Clinical Oncology
- Optimization of IL13Rα2-Targeted Chimeric Antigen Receptor T Cells for Improved Anti-tumor Efficacy against Glioblastoma
- (2018) Christine E. Brown et al. MOLECULAR THERAPY
- Targeting the tumour stroma to improve cancer therapy
- (2018) Kenneth C. Valkenburg et al. Nature Reviews Clinical Oncology
- Dexamethasone-induced immunosuppression: mechanisms and implications for immunotherapy
- (2018) Amber J. Giles et al. Journal for ImmunoTherapy of Cancer
- Two-Dimensional Regulation of CAR-T Therapy with Orthogonal Switches
- (2018) MyLinh T. Duong et al. Molecular Therapy-Oncolytics
- CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy
- (2017) Terry J Fry et al. NATURE MEDICINE
- A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma
- (2017) Donald M. O’Rourke et al. Science Translational Medicine
- HER2-Specific Chimeric Antigen Receptor–Modified Virus-Specific T Cells for Progressive Glioblastoma
- (2017) Nabil Ahmed et al. JAMA Oncology
- Engineering T Cells with Customized Therapeutic Response Programs Using Synthetic Notch Receptors
- (2016) Kole T. Roybal et al. CELL
- Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
- (2016) Christine E. Brown et al. NEW ENGLAND JOURNAL OF MEDICINE
- T Cells Expressing CD19/CD20 Bispecific Chimeric Antigen Receptors Prevent Antigen Escape by Malignant B Cells
- (2016) E. Zah et al. Cancer Immunology Research
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started